Company Dossier · Materials
Avery Dennison
- S&P 500
- Russell 1000
What Avery Dennison is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.
Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →
The latest read
Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.
- Revenue over the four quarters to June 30, 2026: $9.25 billion, up 5.8% from a year earlier.SEC EDGAR filings (XBRL)
- Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $1.06 billion, up 66% from a year earlier.SEC EDGAR filings (XBRL)
- Capital expenditure over the four quarters to June 30, 2026: $0.17 billion, down 5.6% from a year earlier.SEC EDGAR filings (XBRL)
- Share buybacks in the fiscal year to December 31, 2025: $0.57 billion.SEC EDGAR filings (10-K)
- Long-term debt issued in the fiscal year to December 31, 2025: $0.58 billion.SEC EDGAR filings (10-K)
- Latest earnings call or results release (July 30, 2026): sentiment 0.40 on a −1 to +1 scale (mixed), confidence 0.70 of 1.Palanor Discourse
- Latest annual report (filed February 25, 2026): 0 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
- Insiders were net sellers in Q3 2026: $1.0 million on the open market.SEC Form 4
- 786 institutional managers reported a position at June 30, 2026 (−8 on the quarter before).SEC Form 13F
- H-1B filings certified in Q2 2026: 10 (15 a year earlier).U.S. Department of Labor (OFLC)
Risk events (12 months): 3 — latest OSHA inspection, Jul 7, 2026 →
Company Posture
How Company Posture is measured →What Avery Dennison is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.
Steady · Mixed
Expanding ↔ Retrenching
Steady
- Capital spending71st pct
- Debt raised—
- Buybacks vs capex26th pct
- Hiring filings11th pct
- Deals and private raises47th pct
- Patent publications48th pct
Confident ↔ Hedging
Mixed
- Call sentiment67th pct
- Call confidence52nd pct
- Guidance changes51st pct
- Risk factors added76th pct
- Insider open-market trades43rd pct
- + Call sentiment
- + Risk factors added
- − Insider open-market trades
Pressure
Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).
- Fails-to-deliver39th pct
- Stress filings48th pct
Credit
How these are built →Avery Dennison's borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.
Debt on the balance sheet
$3.7B
- Due within a year $0.5B
- Longer term $3.2B
- Default point $2.1B (short + ½ long)
Finance leases included · Jun 30, 2026 filing
Bonds priced, last 12 months
None
U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.
| Priced | Amount | Coupon | Matures | Spread | Yield |
|---|---|---|---|---|---|
| Sep 8, 2025 | €500M | 4.000% | 2035 (10y) | +143bp | 4.075% |
| Oct 30, 2024 | €500M | 3.750% | 2034 (10y) | +141bp | 3.790% |
From the pricing term sheets Avery Dennison filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.
Charts
Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.
Cash flow
Capital returned and raised
What the company says
Hiring and ownership
Filings and records
The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.
- Oct 20, 2026LobbyingLobbying report (AVERY DENNISON CORPORATION)third_quarter 2026 · $0.0 million
- Oct 16, 2026LobbyingLobbying report (BRACEWELL LLP)third_quarter 2026 · $0.1 million
- Oct 13, 20268-KDirector or officer changeItem 5.02
- Oct 5, 20268-KDirector or officer changeItem 5.02
- Sep 29, 2026Patent
- Aug 18, 2026PatentPatent granted: ADHESIVE TAPE ASSEMBLIESUS 12708573
- Jul 28, 2026Patent
- Jul 20, 2026LobbyingLobbying report (AVERY DENNISON CORPORATION)second_quarter 2026 · $0.0 million
- Jul 15, 2026LobbyingLobbying report (BRACEWELL LLP)second_quarter 2026 · $0.1 million
- Jul 14, 2026Patent
- Jul 7, 2026Patent
- Jul 7, 2026Risk event
- Jun 4, 20268-KDirector or officer changeItem 5.02
- May 1, 20268-KShareholder vote resultsItem 5.07
- Apr 20, 2026LobbyingLobbying report (BRACEWELL LLP)first_quarter 2026 · $0.1 million
- Apr 20, 2026LobbyingLobbying report (AVERY DENNISON CORPORATION)first_quarter 2026 · $0.0 million
- Apr 15, 2026Risk event
- Apr 15, 2026Risk event
- Feb 25, 202610-KAnnual report (10-K)0 risk factors added, 0 removed
- Jan 20, 2026LobbyingLobbying report (AVERY DENNISON CORPORATION)fourth_quarter 2025 · $0.0 million
- Jan 16, 2026LobbyingLobbying report (BRACEWELL LLP)fourth_quarter 2025 · $0.1 million
- Sep 11, 20258-KMaterial agreement signedItem 1.01
- Jul 24, 20258-KDirector or officer changeItem 5.02
- Apr 28, 20258-KShareholder vote resultsItem 5.07
- Mar 31, 20258-KDirector or officer changeItem 5.02
- Feb 26, 202510-KAnnual report (10-K)0 risk factors added, 2 removed
- Jan 2, 20258-KDirector or officer changeItem 5.02
- Nov 15, 20248-KDirector or officer changeItem 5.02
- Nov 8, 20248-KDirector or officer changeItem 5.02
- Nov 4, 20248-KMaterial agreement signedItem 1.01
- Feb 21, 202410-KAnnual report (10-K)1 risk factors added, 2 removed
Peers
Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.
| Company | Revenue | Free cash flow | Through |
|---|---|---|---|
| Packaging Corporation of America PKG | $9.5B | $0.7B | Jun 30, 2026 |
| Sonoco SON | $7.5B | $0.2B | Mar 29, 2026 |
| Amcor AMCR | $23.5B | $1.2B | Jun 30, 2026 |
| International Paper IP | $24.2B | $0.5B | Jun 30, 2026 |
| Smurfit Westrock SW | $31.3B | $1.0B | Jun 30, 2026 |
| Commercial Metals CMC | $9.4B | $0.5B | Aug 31, 2026 |
| Eastman Chemical Company EMN | $8.9B | $0.5B | Jun 30, 2026 |
| Celanese CE | $9.7B | $0.7B | Jun 30, 2026 |